☰

Suresh Thareja - Publications

Affiliations: 
2017 Georgia State University, Atlanta, GA, United States 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bhatia N, Khator R, Kulkarni S, Singh Y, Kumar P, Thareja S. Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer. Current Medicinal Chemistry. 30: 3668-3701. PMID 37190755 DOI: 10.2174/0929867330666221114103924  0.342
2020 Liao P, Bhattarai N, Cao B, Zhou X, Jung JH, Damera K, Fuselier TT, Thareja S, Wimley WC, Wang B, Zeng SX, Lu H. Crotonylation at serine 46 impairs p53 activity. Biochemical and Biophysical Research Communications. PMID 32035620 DOI: 10.1016/J.Bbrc.2020.01.152  0.503
2020 Banjare L, Verma SK, Jain AK, Thareja S. Lead Molecules as Novel Aromatase Inhibitors: In Silico-De Novo Designing and Binding Affinity Studies Letters in Drug Design & Discovery. 16: 655-665. DOI: 10.2174/1570180816666190703152659  0.339
2019 Verma SK, Yadav YS, Thareja S. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018). Mini Reviews in Medicinal Chemistry. 19: 591-598. PMID 30968766 DOI: 10.2174/1389557518666181026092029  0.387
2019 Banjare L, Verma SK, Jain AK, Thareja S. Structure Guided Molecular Docking Assisted Alignment Dependent 3D-QSAR Study On Steroidal Aromatase Inhibitors (SAIs) As Anti-Breast Cancer Agents Letters in Drug Design & Discovery. 15: 808-817. DOI: 10.2174/1570180815666181010101024  0.313
2018 Liang C, Tian D, Ren X, Ding S, Jia M, Xin M, Thareja S. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. European Journal of Medicinal Chemistry. 151: 315-326. PMID 29631132 DOI: 10.1016/J.Ejmech.2018.03.062  0.381
2018 Xin M, Ji X, De La Cruz LK, Thareja S, Wang B. Strategies to target the Hedgehog signaling pathway for cancer therapy. Medicinal Research Reviews. PMID 29315702 DOI: 10.1002/Med.21482  0.484
2017 Verma SK, Thareja S. Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors. Plos One. 12: e0175318. PMID 28399135 DOI: 10.1371/Journal.Pone.0175318  0.343
2017 Thareja S, Zhu M, Ji X, Wang B. Boron-based small molecules in disease detection and treatment (2013–2016) Heterocyclic Communications. 23: 137-153. DOI: 10.1515/Hc-2017-0086  0.546
2016 Verma SK, Thareja S. Formylchromone derivatives as novel and selective PTP-1B inhibitors: a drug design aspect using molecular docking-based self-organizing molecular field analysis Medicinal Chemistry Research. 25: 1433-1467. DOI: 10.1007/S00044-016-1584-0  0.356
Show low-probability matches.